OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2024
(2)
2021
(1)
2019
(1)
2017
(1)
2015
(1)
2011
(1)
2009
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Determinants of the assembly and function of antibody variable domains.
Not available
S-EPMC5613017
|
biostudies-literature
Cite
RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
Not available
S-EPMC4615291
|
biostudies-literature
Cite
Prognostic impact of targetable driver alterations in resected early-stage lung cancer.
Not available
S-EPMC11632426
|
biostudies-literature
Cite
Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia.
Not available
S-EPMC7080291
|
biostudies-literature
Cite
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Not available
S-EPMC3145073
|
biostudies-literature
Cite
Timing of Major Postoperative Bleeding Among Patients Undergoing Surgery.
Not available
S-EPMC10988355
|
biostudies-literature
Cite
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
Not available
S-EPMC8532039
|
biostudies-literature
Cite
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Not available
S-EPMC2806600
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets